Apria Inc (APR) Return on Investment ROI from the fourth quarter of 2021 to fourth quarter of 2020 and for the year 2021, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket
 


Apria inc   (NASDAQ: APR)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare


Apria Inc's ROI from its fourth quarter of 2021 to the fourth quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Apria Inc's ROI in the fourth quarter of 2021?
Apria inc achieved a return on average invested assets (ROI) of 11.99 % in its fourth quarter of 2021 a new company high.

ROI decreased relative to the period ending Sep 30 2021, due to the decline in net income.

Within the Healthcare sector 113 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2021 from 0 to 952.

Definition and Formula of Return on Investment



Return On Investment (Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Investment Change TTM 385.6 % - - - -
Y / Y Net Income Change TTM 40.61 % 264.11 % 289.15 % 587.13 % -
Investment (TTM) in Millions 469 455 440 801 446
Return On Investment (TTM) 11.99 % 13.78 % 13.44 % 14.2 % 41.4 %
APR's Overall Ranking # 952 # 0 # 0 # 0 #
Seq. Investment Change TTM 1.07 % 26.96 % 35.32 % 179.65 % -
Seq. Net Income Change TTM -12.09 % 30.17 % 28.13 % -4.11 % 127.64 %
Net Income (TTM) in Millions 65 74 57 44 46




Return On Investment APR's Ranking
Within: No.
Industry # 7
Sector # 114
Overall # 952

Return On Investment Statistics
High Average Low
11.99 %
7.13 %
2.27 %
(Dec 31 2021)   (Mar 31 2021)







Financial Statements
Apria Inc's IV. Quarter Investments $ 469 Millions APR's Balance sheet
Apria Inc's IV. Quarter Income $ 17 Millions Quarterly APR's Income Statement
APR's Income by Division See APR's Income by Division


APR Annual Return On Investment (Dec 31 2021)
2021




Total Investments in Millions 469 0 0 0 0
Y / Y Investment Growth - - - - -
Net Income in Millions 65 0 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 13.84 % - - - -


Annual Roi Comment
In the fiscal year 2021 ROI improved to 13.84 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Healthcare Facilities Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
APR's Roi Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for APR's Competitors
Subscribers only: Roi for Apria Inc's Suppliers
Subscribers only: Return On Investment for APR's Customers

Other Ratios
APR's Roa APR's Inventory Turnover Ratio APR's Growth Rates APR's Dividend Statistics
APR's Profitability Ratios APR's Asset Turnover Ratio APR's Dividend Growth
APR's Roe APR's Valuation Ratios APR's Financial Strength Ratios APR's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI
Nrc Health  32.87 %
Genfit S a   30.73 %
Progyny Inc   29.29 %
Antares Pharma Inc   28.50 %
Incyte Corporation  27.46 %
West Pharmaceutical Services Inc   26.42 %
Bio rad Laboratories Inc   26.15 %
Elite Pharmaceuticals Inc   25.11 %
Sunlink Health Systems Inc   24.91 %
Sonida Senior Living Inc   24.82 %
Exelixis Inc   24.58 %
La Jolla Pharmaceutical Company  23.85 %
Chemed Corporation  23.34 %
Corcept Therapeutics Inc  23.06 %
Hologic Inc  22.69 %
Vertex Pharmaceuticals Inc  22.02 %
Tivity Health Inc   21.97 %
Edwards Lifesciences Corporation  21.86 %
Zynex inc   20.95 %
Align Technology inc   20.34 %
Lftd Partners Inc   20.12 %
Catalyst Pharmaceuticals Inc   20.01 %
Maravai Lifesciences Holdings Inc   19.66 %
Atea Pharmaceuticals Inc   19.53 %
Novo Nordisk A  18.97 %
Lifevantage Corp  18.81 %
Sensus Healthcare Inc   18.28 %
Novartis Ag  18.26 %
Waters Corporation  18.12 %
Dynavax Technologies Corporation  18.08 %


Date modified: 2026-09-08T15:10:30+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.